Annotation for this protein is in progress - please check future releases for more complete information



DP00428: Serine/threonine-protein kinase PLK1FASTA viewXML view

General information
DisProt:DP00428
Name:Serine/threonine-protein kinase PLK1
Synonym(s):PLK1_HUMAN
Polo-like kinase 1
PLK-1
Serine/threonine-protein kinase 13
STPK13
First appeared in release:Release 3.0 (02/17/2006)
UniProt:P53350
UniGene:Hs.592049
SwissProt: PLK1_HUMAN
TrEMBL:  
NCBI (GI): 1709658
Source organism:Homo sapiens (Human)
Sequence length:603
Percent disordered:9%
Homologues: 


Native sequence

        10         20         30         40         50         60
         |          |          |          |          |          |
MSAAVTAGKL ARAPADPGKA GVPGVAAPGA PAAAPPAKEI PEVLVDPRSR RRYVRGRFLG - 60
KGGFAKCFEI SDADTKEVFA GKIVPKSLLL KPHQREKMSM EISIHRSLAH QHVVGFHGFF - 120
EDNDFVFVVL ELCRRRSLLE LHKRRKALTE PEARYYLRQI VLGCQYLHRN RVIHRDLKLG - 180
NLFLNEDLEV KIGDFGLATK VEYDGERKKT LCGTPNYIAP EVLSKKGHSF EVDVWSIGCI - 240
MYTLLVGKPP FETSCLKETY LRIKKNEYSI PKHINPVAAS LIQKMLQTDP TARPTINELL - 300
NDEFFTSGYI PARLPITCLT IPPRFSIAPS SLDPSNRKPL TVLNKGLENP LPERPREKEE - 360
PVVRETGEVV DCHLSDMLQQ LHSVNASKPS ERGLVRQEEA EDPACIPIFW VSKWVDYSDK - 420
YGLGYQLCDN SVGVLFNDST RLILYNDGDS LQYIERDGTE SYLTVSSHPN SLMKKITLLK - 480
YFRNYMSEHL LKAGANITPR EGDELARLPY LRTWFRTRSA IILHLSNGSV QINFFQDHTK - 540
LILCPLMAAV TYIDEKRDFR TYRLSLLEEY GCCKELASRL RYARTMVDKL LSSRSASNRL - 600
KAS



Functional narrative    

Serine/threonine-protein kinase that performs several important functions throughout M phase of the cell cycle, including the regulation of centrosome maturation and spindle assembly, the removal of cohesins from chromosome arms, the inactivation of APC/C inhibitors, and the regulation of mitotic exit and cytokinesis.

Region 2: 345-372 Region 1: 493-507 Region 3: 594-603

Map of ordered and disordered regions







Note: 'Mouse' over a region to see the start and stop residues. Click on a region to see detailed information.


Region 1
Type:Disordered
Name: 
Location:493 - 507
Length:15
Region sequence:

AGANITPREGDELAR

Modification type: Fragment
PDB:  
Structural/functional type: Function arises via a disorder to order transition
Functional classes: Entropic chain
Functional subclasses: Flexible linkers/spacers
Detection methods:
  1. X-ray crystallography (277 K; Ammonium acetate 0.1 M; PEG 4000 (5-10% (v/v)); protein 10 mg/ml; Sodium citrate (pH 6.0) 0.1 M)

References:
  1. Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN. "The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex." EMBO J. 2003; 22(21): 5757-68. PubMed: 14592974

Comments:
The fragment used to determine this structure consisted of residues 345-603.




Region 2
Type:Disordered
Name: 
Location:345 - 372
Length:28
Region sequence:

KGLENPLPERPREKEEPVVRETGEVVDC

Modification type: Complex
Fragment
PDB:  
Structural/functional type: Relationship to function unknown
Functional classes: Unknown
Functional subclasses: Unknown
Detection methods:
  1. X-ray crystallography (298 K; MES (pH 6.5) 0.1 M; PEG 20000 (1-10%); Phospho-peptide (Met.Gln.Ser.pThr.Pro.Leu); protein 10 mg/ml)

References:
  1. Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN. "The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex." EMBO J. 2003; 22(21): 5757-68. PubMed: 14592974

Comments:
The fragment used to determine this structure consisted of residues 345-603.




Region 3
Type:Disordered
Name: 
Location:594 - 603
Length:10
Region sequence:

RSASNRLKAS

Modification type: Complex
Fragment
PDB:  
Structural/functional type: Relationship to function unknown
Functional classes: Unknown
Functional subclasses: Unknown
Detection methods:
  1. X-ray crystallography (298 K; MES (pH 6.5) 0.1 M; PEG 20000 (1-10%); Phospho-peptide (Met.Gln.Ser.pThr.Pro.Leu); protein 10 mg/ml)

References:
  1. Cheng KY, Lowe ED, Sinclair J, Nigg EA, Johnson LN. "The crystal structure of the human polo-like kinase-1 polo box domain and its phospho-peptide complex." EMBO J. 2003; 22(21): 5757-68. PubMed: 14592974

Comments:
The fragment used to determine this structure consisted of residues 345-603.



If you have any comments or wish to provide additional references to this protein or its disordered region(s), please click here to e-mail us.


Disprot-footer
Contact us